Entries by CAPTIS

Janssen gets EC approval for Ebola vaccine regimen

As a result of the approval, Janssen is currently collaborating with the World Health Organisation (WHO) on vaccine pre-qualification to advance the registration of its preventive Ebola vaccine The post Janssen gets EC approval for Ebola vaccine regimen appeared first on Pharmaceutical Business review.

Oncternal Therapeutics gets FDA orphan drug designations for cirmtuzumab ROR1 antibody to treat MCL and CLL

Cirmtuzumab is an investigational anti-ROR1 monoclonal antibody being evaluated in clinical trials in patients with MCL, CLL and HER2-negative breast cancer. Under the Orphan Drug Act, the FDA The post Oncternal Therapeutics gets FDA orphan drug designations for cirmtuzumab ROR1 antibody to treat MCL and CLL appeared first on Pharmaceutical Business review.